��������

Aaron Scheinfeld serves as the President and Chief Operating Officer at Myodetox since August 2019, where responsibilities also include roles as Chief Operating Officer and Chief Business Officer. Prior experience includes consulting for Barry's from June 2018 to July 2019, work as a Private Equity Associate at Berkshire Partners from August 2015 to August 2017, and serving as an Investment Banking Analyst at Morgan Stanley from June 2013 to July 2015. Aaron Scheinfeld holds a Master of Business Administration from Harvard Business School, completed between 2017 and 2019, and earned a Bachelor of Arts, Summa Cum Laude, from Princeton University in the Princeton School of Public and International Affairs from 2009 to 2013. Early education was at Horace Mann School from 2005 to 2009.